# Metabolomic Profiling of Novel Mediators of Vascular Function

> **NCT00762242** · — · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 48 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **PROCEDURE:** blood sampling and brachial artery ultrasound

## Key facts

- **NCT ID:** NCT00762242
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Study enrollment was no adequate.
- **Last updated:** 2016-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00762242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00762242, "Metabolomic Profiling of Novel Mediators of Vascular Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00762242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*